These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29625253)

  • 21. Zwitterionic nanoparticles constructed from bioreducible RAFT-ROP double head agent for shell shedding triggered intracellular drug delivery.
    Huang P; Liu J; Wang W; Zhang Y; Zhao F; Kong D; Liu J; Dong A
    Acta Biomater; 2016 Aug; 40():263-272. PubMed ID: 26607767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and discrimination of autoimmune Graves' disease and Hashimoto's disease using thyroid-stimulating hormone receptor-containing recombinant proteoliposomes.
    Fukushima H; Matsuo H; Imamura K; Morino K; Okumura K; Tsumoto K; Yoshimura T
    J Biosci Bioeng; 2009 Dec; 108(6):551-6. PubMed ID: 19914592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcutaneous drug delivery by liposomes using fractional laser technology.
    Fujimoto T; Wang J; Baba K; Oki Y; Hiruta Y; Ito M; Ito S; Kanazawa H
    Lasers Surg Med; 2017 Jul; 49(5):525-532. PubMed ID: 27990655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation of targeting proteoliposome by postinsertion of a linker molecule conjugated with recombinant human epidermal growth factor.
    Hwang SY; Cho DY; Kim HK; Cho SH; Choo J; Yoon WJ; Lee EK
    Bioconjug Chem; 2010 Feb; 21(2):345-51. PubMed ID: 20078100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rhodopsin activity varies in proteoliposomes prepared by different techniques.
    Niu SL; Doctrow B; Mitchell DC
    Biochemistry; 2009 Jan; 48(1):156-63. PubMed ID: 19090672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liposome-based immunity-inducing systems for cancer immunotherapy.
    Yuba E
    Mol Immunol; 2018 Jun; 98():8-12. PubMed ID: 29128232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cadherin-integrated liposomes with potential application in a drug delivery system.
    Kamiya K; Tsumoto K; Yoshimura T; Akiyoshi K
    Biomaterials; 2011 Dec; 32(36):9899-907. PubMed ID: 21944724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fusion behaviour of aquaporin Z incorporated proteoliposomes investigated by quartz crystal microbalance with dissipation (QCM-D).
    Li X; Wang R; Wicaksana F; Zhao Y; Tang C; Torres J; Fane AG
    Colloids Surf B Biointerfaces; 2013 Nov; 111():446-52. PubMed ID: 23850749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-Throughput E. coli Cell-Free Expression: From PCR Product Design to Functional Validation of GPCR.
    Cortès S; Hibti FE; Chiraz F; Ezzine S
    Methods Mol Biol; 2019; 2025():261-279. PubMed ID: 31267457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A tumor vasculature targeted liposome delivery system for combretastatin A4: design, characterization, and in vitro evaluation.
    Nallamothu R; Wood GC; Pattillo CB; Scott RC; Kiani MF; Moore BM; Thoma LA
    AAPS PharmSciTech; 2006 Apr; 7(2):E32. PubMed ID: 16796350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-free expression and assembly of ATP synthase.
    Matthies D; Haberstock S; Joos F; Dötsch V; Vonck J; Bernhard F; Meier T
    J Mol Biol; 2011 Oct; 413(3):593-603. PubMed ID: 21925509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer.
    Wang F; Chen L; Zhang R; Chen Z; Zhu L
    J Control Release; 2014 Dec; 196():222-33. PubMed ID: 25456829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineered liposomes and virosomes for delivery of macromolecules.
    Grimaldi S; Giuliani A; Giuliani A; Ferroni L; Lisi A; Santoro N; Pozzi D
    Res Virol; 1995; 146(4):289-93. PubMed ID: 8539492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-Free Production of Proteoliposomes for Functional Analysis and Antibody Development Targeting Membrane Proteins.
    Zhou W; Takeda H
    J Vis Exp; 2020 Sep; (163):. PubMed ID: 33044457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromatographic approaches to liposomes, proteoliposomes and biomembrane vesicles.
    Lundahl P; Zeng CM; Lagerquist Hägglund C; Gottschalk I; Greijer E
    J Chromatogr B Biomed Sci Appl; 1999 Feb; 722(1-2):103-20. PubMed ID: 10068136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liposomes in ultrasonic drug and gene delivery.
    Huang SL
    Adv Drug Deliv Rev; 2008 Jun; 60(10):1167-76. PubMed ID: 18479776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liposomal drug delivery systems--clinical applications.
    Goyal P; Goyal K; Vijaya Kumar SG; Singh A; Katare OP; Mishra DN
    Acta Pharm; 2005 Mar; 55(1):1-25. PubMed ID: 15907221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of cholesterol-poly(N,N-dimethylaminoethyl methacrylate) on the properties of stimuli-responsive polymer liposome complexes.
    Alves P; Hugo AA; Tymczyszyn EE; Ferreira AF; Fausto R; Pérez PF; Coelho JF; Simões PN; Gómez-Zavaglia A
    Colloids Surf B Biointerfaces; 2013 Apr; 104():254-61. PubMed ID: 23333913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microfluidic synthesis of multifunctional liposomes for tumour targeting.
    Ran R; Middelberg APJ; Zhao CX
    Colloids Surf B Biointerfaces; 2016 Dec; 148():402-410. PubMed ID: 27639490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant proteoliposomes prepared using baculovirus expression systems.
    Tsumoto K; Yoshimura T
    Methods Enzymol; 2009; 465():95-109. PubMed ID: 19913163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.